Latest hum. ProductsDetails
Product Name in the RMS: Caramlo 8 mg/5 mg Tabletten
MR Number: DE/H/3677/001
Date of outcome: 20.03.2014
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Fixed Combination Chemical Substance Prescription Only |
| Active Substances |
amlodipine besilate 6,94 mg candesartancilexetil 8 mg |
| Form | Tablet |
| MA Holder in the RMS |
Zentiva Pharma GmbH Brüningstr. 50 D-65926 Frankfurt am Main Germany |
| RMS | Germany |
| Date of last change | 03.12.2020 |
| ATC-Code |
C09DB Angiotensin II antagonists and calcium channel blockers |
| CMS Country | Domestic Product Name |
|---|---|
| Bulgaria | Caramlo |
| Cyprus | CARAMLO TABS |
| Czech Republic | Caramlo 8mg/5mg tablety |
| Estonia | ZENICAMO |
| Greece | |
| Hungary | ZENICAMO 8 mg/5 mg tabletta |
| Latvia | |
| Lithuania | |
| Poland | Caramlo |
| Portugal | |
| Romania | Caramlo 8 mg/5 mg comprimate |
| Documents | |
|---|---|
| PAR: | DE_H_3677_001_PAR.pdf (29.09.2015) |
| FinalSPC: | DE_H_3677_001_FinalSPC.pdf (11.04.2014) |
| Finalised Product Information: | DE_H_3677_001_FinalPI_1of2.pdf (17.01.2019) |
| Finalised Product Information: | DE_H_3677_001_FinalPI_2of2.pdf (17.01.2019) |
